A brain-dedicated scanner is changing what doctors can see. CT researchers say that ‘opens the door’
The ability to follow patients with this high sensitivity allows us to make a more accurate and precise measurement, and we can see small changes or see them in a shorter period of time…,” ...
Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary Cancers Symposium later this week in San Francisco, California. The new ...
Maximum tumor diameter (MTD) showed a strong association with the risk for relapse in patients with limited-stage Hodgkin lymphoma (HL) achieving PET negativity, with each centimeter increase in MTD ...
Real-world data shows a clear association between increased tumor size and mortality in brain cancer patients. Early diagnosis using Dxcover's PANAROMIC liquid biopsy platform can reduce mortality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results